Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

Fortunato Morabito; Francesco Morabito; Giovanni Tripepi; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Sabrina Bossio; Marzia Varettoni; Roberta Murru; Annalisa Chiarenza; Andrea Visentin; Adalgisa Condoluci; Riccardo Moia; Daniela Pietrasanta; Giacomo Loseto; Ugo Consoli; Ilaria Scortechini; Francesca Maria Rossi; Federica Maria Rossi; Antonella Zucchetto; Hamdi Al-Janazreh; Ernesto Vigna; Enrica Antonia Martino; Ramona Cassin; Graziella D′Arrigo; Sara Galimberti; Sofia Galimberti; Angela Rago; Ilaria Angeletti; Annalisa Biagi; Ilaria Del Giudice; Riccardo Bomben; Antonino Neri; Gilberto Fronza; Paola Monti; Paolo Monti; Paola Menichini; Jacopo Olivieri; Giovanna Cutrona; Davide Rossi; Dario Rossi; Antonio Cuneo; Francesco Di Raimondo; Gianluca Gaidano; Aaron Polliack; Livio Trentin; Robin Foà; Robin Foa; Manlio Ferrarini; Valter Gattei; Massimo Gentile; Marino Gentile

doi:10.1002/ajh.26201

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

Fortunato Morabito, Francesco Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo ConsoliIlaria Scortechini, Francesca Maria Rossi, Federica Maria Rossi, Antonella Zucchetto, Hamdi Al-Janazreh, Ernesto Vigna, Enrica Antonia Martino, Ramona Cassin, Graziella D′Arrigo, Sara Galimberti, Sofia Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Paola Monti, Paolo Monti, Paola Menichini, Jacopo Olivieri, Giovanna Cutrona, Davide Rossi, Dario Rossi, Antonio Cuneo, Francesco Di Raimondo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Robin Foa, Manlio Ferrarini, Valter Gattei, Massimo Gentile, Marino Gentile

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

n/a

Lingua originale	English
pagine (da-a)	E269-E272
Rivista	American Journal of Hematology
Volume	96
DOI	https://doi.org/10.1002/ajh.26201
Stato di pubblicazione	Pubblicato - 2021

Keywords

Adenine
Aged
Bendamustine Hydrochloride
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Piperidines
Progression-Free Survival
Rituximab

Accesso al documento

10.1002/ajh.26201

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Morabito, F., Morabito, F., Tripepi, G., Del Poeta, G., Mauro, F. R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Bossio, S., Varettoni, M., Murru, R., Chiarenza, A., Visentin, A., Condoluci, A., Moia, R., Pietrasanta, D., Loseto, G., ... Gentile, M. (2021). Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. American Journal of Hematology, 96, E269-E272. https://doi.org/10.1002/ajh.26201

@article{26f06251c66146c5bcc47b9b2e351817,

title = "Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials",

abstract = "n/a",

keywords = "Adenine, Aged, Bendamustine Hydrochloride, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Piperidines, Progression-Free Survival, Rituximab, Adenine, Aged, Bendamustine Hydrochloride, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Piperidines, Progression-Free Survival, Rituximab",

author = "Fortunato Morabito and Francesco Morabito and Giovanni Tripepi and {Del Poeta}, Giovanni and Mauro, {Francesca Romana} and Gianluigi Reda and Paolo Sportoletti and Luca Laurenti and Marta Coscia and Yair Herishanu and Sabrina Bossio and Marzia Varettoni and Roberta Murru and Annalisa Chiarenza and Andrea Visentin and Adalgisa Condoluci and Riccardo Moia and Daniela Pietrasanta and Giacomo Loseto and Ugo Consoli and Ilaria Scortechini and Rossi, {Francesca Maria} and Rossi, {Federica Maria} and Antonella Zucchetto and Hamdi Al-Janazreh and Ernesto Vigna and Martino, {Enrica Antonia} and Ramona Cassin and Graziella D′Arrigo and Sara Galimberti and Sofia Galimberti and Angela Rago and Ilaria Angeletti and Annalisa Biagi and {Del Giudice}, Ilaria and Riccardo Bomben and Antonino Neri and Gilberto Fronza and Paola Monti and Paolo Monti and Paola Menichini and Jacopo Olivieri and Giovanna Cutrona and Davide Rossi and Dario Rossi and Antonio Cuneo and {Di Raimondo}, Francesco and Gianluca Gaidano and Aaron Polliack and Livio Trentin and Robin Fo{\`a} and Robin Foa and Manlio Ferrarini and Valter Gattei and Massimo Gentile and Marino Gentile",

year = "2021",

doi = "10.1002/ajh.26201",

language = "English",

volume = "96",

pages = "E269--E272",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

}

Morabito, F, Morabito, F, Tripepi, G, Del Poeta, G, Mauro, FR, Reda, G, Sportoletti, P, Laurenti, L, Coscia, M, Herishanu, Y, Bossio, S, Varettoni, M, Murru, R, Chiarenza, A, Visentin, A, Condoluci, A, Moia, R, Pietrasanta, D, Loseto, G, Consoli, U, Scortechini, I, Rossi, FM, Rossi, FM, Zucchetto, A, Al-Janazreh, H, Vigna, E, Martino, EA, Cassin, R, D′Arrigo, G, Galimberti, S, Galimberti, S, Rago, A, Angeletti, I, Biagi, A, Del Giudice, I, Bomben, R, Neri, A, Fronza, G, Monti, P, Monti, P, Menichini, P, Olivieri, J, Cutrona, G, Rossi, D, Rossi, D, Cuneo, A, Di Raimondo, F, Gaidano, G, Polliack, A, Trentin, L, Foà, R, Foa, R, Ferrarini, M, Gattei, V, Gentile, M & Gentile, M 2021, 'Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials', American Journal of Hematology, vol. 96, pagg. E269-E272. https://doi.org/10.1002/ajh.26201

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. / Morabito, Fortunato; Morabito, Francesco; Tripepi, Giovanni et al.
In: American Journal of Hematology, Vol. 96, 2021, pag. E269-E272.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

AU - Morabito, Fortunato

AU - Morabito, Francesco

AU - Tripepi, Giovanni

AU - Del Poeta, Giovanni

AU - Mauro, Francesca Romana

AU - Reda, Gianluigi

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Coscia, Marta

AU - Herishanu, Yair

AU - Bossio, Sabrina

AU - Varettoni, Marzia

AU - Murru, Roberta

AU - Chiarenza, Annalisa

AU - Visentin, Andrea

AU - Condoluci, Adalgisa

AU - Moia, Riccardo

AU - Pietrasanta, Daniela

AU - Loseto, Giacomo

AU - Consoli, Ugo

AU - Scortechini, Ilaria

AU - Rossi, Francesca Maria

AU - Rossi, Federica Maria

AU - Zucchetto, Antonella

AU - Al-Janazreh, Hamdi

AU - Vigna, Ernesto

AU - Martino, Enrica Antonia

AU - Cassin, Ramona

AU - D′Arrigo, Graziella

AU - Galimberti, Sara

AU - Galimberti, Sofia

AU - Rago, Angela

AU - Angeletti, Ilaria

AU - Biagi, Annalisa

AU - Del Giudice, Ilaria

AU - Bomben, Riccardo

AU - Neri, Antonino

AU - Fronza, Gilberto

AU - Monti, Paola

AU - Monti, Paolo

AU - Menichini, Paola

AU - Olivieri, Jacopo

AU - Cutrona, Giovanna

AU - Rossi, Davide

AU - Rossi, Dario

AU - Cuneo, Antonio

AU - Di Raimondo, Francesco

AU - Gaidano, Gianluca

AU - Polliack, Aaron

AU - Trentin, Livio

AU - Foà, Robin

AU - Foa, Robin

AU - Ferrarini, Manlio

AU - Gattei, Valter

AU - Gentile, Massimo

AU - Gentile, Marino

PY - 2021

Y1 - 2021

N2 - n/a

AB - n/a

KW - Adenine

KW - Aged

KW - Bendamustine Hydrochloride

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell

KW - Piperidines

KW - Progression-Free Survival

KW - Rituximab

KW - Adenine

KW - Aged

KW - Bendamustine Hydrochloride

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell

KW - Piperidines

KW - Progression-Free Survival

KW - Rituximab

UR - http://hdl.handle.net/10807/184831

U2 - 10.1002/ajh.26201

DO - 10.1002/ajh.26201

M3 - Article

SN - 0361-8609

VL - 96

SP - E269-E272

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo